Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Avonex

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Avonex was produced by Biogen Idec.

New accounts: January

Biogen. Avonex. Multiple sclerosis. Brader Perryman. Cambridge Laboratories. Gelclair. Oncology/ENT. RFA Advertising.

Double or quits!

Avonex (Biogen Idec) and Rebif (Serono) are recombinant human inter-feron B-1a products; administration is via subcutaneous (SC) injection once- and thrice-weekly, respectively. ... However, Avonex can also be used for a single neurological event

New accounts: February

Biogen. Avonex. Multiple sclerosis. Brader Perryman. Eden Biodesign. N/A. Corporate. Affiniti (UK).

Turbulent times

The companies revealed that one patient had died after taking Tysabri for two years in combination with Avonex while a second was suspected of developing a central nervous system disease.

Biogen Idec board may sell

Biogen's primary drug portfolio consists of multiple sclerosis (MS) drugs Avonex (interferon beta-1a) and Tysabri (natalizumab), as well as rheumatoid arthritis (RA) and cancer drug Rituxan (rituximab).

[ Previous 5 results ] 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Patients are ready for virtual clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
Keep your audiences close
How getting up close and personal with target audiences can fuel creativity...
The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...

Infographics